Merit Medical Systems
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Merit Medical Systems generated cash of $145,151,000, which is more than the previous year. Cash used in financing activities reached the amount of $559,266,000 last year. Net change in cash is therefore $528,586,000.
Cash Flow
| 2014 | 53.32M | -36.20M | -16.96M |
|---|---|---|---|
| 2015 | 69.45M | -62.01M | -10.23M |
| 2016 | 53.59M | -159.10M | 121.09M |
| 2017 | 62.72M | -146.76M | 96.51M |
| 2018 | 86.53M | -378.82M | 328.28M |
| 2019 | 77.81M | -134.48M | 33.53M |
| 2020 | 165.27M | -58.65M | -95.70M |
| 2021 | 147.23M | -37.16M | -98.43M |
| 2022 | 114.29M | -57.39M | -60.26M |
| 2023 | 145.15M | -175.34M | 559.26M |
MMSI Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 60.55M | 67.75M | 56.91M | 44.32M | 67.35M | 32.33M | 19.17M | 4.17M | 7.35M | 7.45M |
Operating activities | ||||||||||
Net income | 94.41M | 74.51M | 48.45M | -9.84M | 5.45M | 42.01M | 27.52M | 20.12M | 23.80M | 22.97M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 101.29M | 92.19M | 95.78M | 106.81M | 104.35M | 69.54M | 53.58M | 43.75M | 37.42M | 35.92M |
Stock-based compensation expense | 21.33M | 18.04M | 16.09M | 14.33M | 9.38M | 0 | 4.07M | 2.50M | 2.24M | 1.46M |
| Deferred income tax benefit | 21.33M | 18.04M | 16.09M | 14.33M | 9.38M | 0 | 4.07M | 2.50M | 2.24M | 1.46M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | -15.11M | -8.61M | 10.42M | -17.9M | -27.52M | -12.84M | -6.81M | -5.87M | -13.59M |
Inventories | 0 | -47.92M | -25.18M | 29.42M | -27.04M | -28.17M | -17.83M | -3.65M | -13.11M | -9.39M |
Accounts payable | -7.29M | 12.66M | 6.05M | 333K | -2.29M | 15.72M | 417K | -6.83M | 14.76M | 5.32M |
Cash generated by operating activities | 145.15M | 114.29M | 147.23M | 165.27M | 77.81M | 86.53M | 62.72M | 53.59M | 69.45M | 53.32M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 35.05M | 0 | 0 |
Investments In Property Plant And Equipment | -36.70M | -45.02M | -27.93M | -49.27M | -81.49M | -66.33M | -41.2M | -35.05M | -52.91M | -35.89M |
Acquisitions Net | -137.84M | -8.28M | -7.17M | -9.66M | -53.90M | -301.78M | -105.58M | -125.16M | -12.36M | -5.92M |
Cash generated by investing activities | -175.34M | -57.39M | -37.16M | -58.65M | -134.48M | -378.82M | -146.76M | -159.10M | -62.01M | -36.20M |
Financing activities | ||||||||||
Common Stock Issued | 15.58M | 20.07M | 21.30M | 6.63M | 6.25M | 214.99M | 143.81M | 5.27M | 6.66M | 8.14M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | -576K | -866K | 0 | -2.61M | 0 | -86K | 0 | -249K |
Repayments of term debt | 619.57M | -44.93M | -108.5M | -157M | 44.5M | -522.60M | -46.41M | -102.09M | -16.89M | -169.39M |
Cash used in financing activities | 559.26M | -60.26M | -98.43M | -95.70M | 33.53M | 328.28M | 96.51M | 121.09M | -10.23M | -16.96M |
Net Change In Cash | 528.58M | -7.19M | 10.83M | 12.59M | -23.03M | 35.02M | 13.16M | 14.99M | -3.17M | -104K |
Cash at end of period | 589.14M | 60.55M | 67.75M | 56.91M | 44.32M | 67.35M | 32.33M | 19.17M | 4.17M | 7.35M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |